Lux Capital

Activity from announced rounds

Activity in this selectionOct 29, 2026 · AI · Sep 30, 2026

Lux Capital invests in companies emerging from the life sciences, physical sciences and computational sciences, including biotechnology, robotics, aerospace, defence and AI infrastructure.

Its investment approach includes small Seeds, Experiments and Optionality investments that let it engage with technology before a conventional venture case is established. The firm also makes thesis-driven investments and backs founders working on technically difficult problems.

Lux’s Riskgaming programme uses researched scenarios to examine how technological developments interact with geopolitics and national security. That perspective is especially relevant for founders whose commercial opportunity depends on scientific progress, industrial adoption or government demand.

Sources
Rounds participated in
4
Confirmed lead rounds
1
All roles disclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$2B
3 disclosed · full round size, not this investor’s share

By stage

Series A2
Series C+1
Undisclosed1

By primary sector

AI3
Biotech1

By country

United States3
United Kingdom1

Rounds

4 in this selection
22one

22one is a London-based startup developing AI tools for law-enforcement work.

UndisclosedReported venture investment
Participant
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A
Participant
Flapping Airplanes

AI research company developing more efficient model training, GPU execution and inference.

$1BSeries A
Lead
Modal Labs

Optimizes AI inference to reduce compute costs and response time

$750MSeries D
Participant